Piedmont Heart Institute Physicians Perform First FDA-Approved Evoque Valve Replacement System on East Coast
March 30, 2024
March 30, 2024
ATLANTA, Georgia, March 30 -- Piedmont issued the following news release:
Piedmont Heart Institute physicians Vinod H. Thourani, M.D., Pradeep Yadav, M.D., James Stewart, M.D., and Peter Flueckiger, M.D., performed the first Edwards Lifesciences Corporation (NYSE: EW) EVOQUE tricuspid valve replacement system in the East Coast of the U. S. since the transcatheter therapy received U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).
Piedmont Heart Institute physicians Vinod H. Thourani, M.D., Pradeep Yadav, M.D., James Stewart, M.D., and Peter Flueckiger, M.D., performed the first Edwards Lifesciences Corporation (NYSE: EW) EVOQUE tricuspid valve replacement system in the East Coast of the U. S. since the transcatheter therapy received U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).